These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15499378)

  • 21. PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis.
    Wick W; Furnari FB; Naumann U; Cavenee WK; Weller M
    Oncogene; 1999 Jul; 18(27):3936-43. PubMed ID: 10435616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression.
    Huang H; Cheville JC; Pan Y; Roche PC; Schmidt LJ; Tindall DJ
    J Biol Chem; 2001 Oct; 276(42):38830-6. PubMed ID: 11495901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
    Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer.
    Bandyopadhyay S; Pai SK; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Commes T; Piquemal D; Watabe M; Gross S; Wang Y; Huggenvik J; Watabe K
    Cancer Res; 2004 Nov; 64(21):7655-60. PubMed ID: 15520163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation.
    Wang J; Ouyang W; Li J; Wei L; Ma Q; Zhang Z; Tong Q; He J; Huang C
    Cancer Res; 2005 Aug; 65(15):6601-11. PubMed ID: 16061640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of gene GSTP1 silencing via shRNA transfection on androgen independent prostate cancer cell line Du145].
    Jin P; Xie J; Zhu X; Zhou C; Ding X; Yang L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 37(8):807-16. PubMed ID: 22954916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of PTEN/MMAC/TEP1 expression in human prostate cancer cell line DU145 by growth stimuli.
    Bastola DR; Pahwa GS; Lin MF; Cheng PW
    Mol Cell Biochem; 2002 Jul; 236(1-2):75-81. PubMed ID: 12190124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN.
    Davies MA; Koul D; Dhesi H; Berman R; McDonnell TJ; McConkey D; Yung WK; Steck PA
    Cancer Res; 1999 Jun; 59(11):2551-6. PubMed ID: 10363971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-proliferative and apoptosis inducing effect of nimbolide by altering molecules involved in apoptosis and IGF signalling via PI3K/Akt in prostate cancer (PC-3) cell line.
    Raja Singh P; Arunkumar R; Sivakamasundari V; Sharmila G; Elumalai P; Suganthapriya E; Brindha Mercy A; Senthilkumar K; Arunakaran J
    Cell Biochem Funct; 2014 Apr; 32(3):217-28. PubMed ID: 23963693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FAS expression inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to induce apoptosis.
    Bandyopadhyay S; Pai SK; Watabe M; Gross SC; Hirota S; Hosobe S; Tsukada T; Miura K; Saito K; Markwell SJ; Wang Y; Huggenvik J; Pauza ME; Iiizumi M; Watabe K
    Oncogene; 2005 Aug; 24(34):5389-95. PubMed ID: 15897909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTEN/MMAC1 enhances the growth inhibition by anticancer drugs with downregulation of IGF-II expression in gastric cancer cells.
    Hwang PH; Kim SY; Lee JC; Kim SJ; Yi HK; Lee DY
    Exp Mol Med; 2005 Oct; 37(5):391-8. PubMed ID: 16264263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Suppression of insulin-like growth factor-1 receptor by RNA interference inhibits cell growth in vitro and induces chemosensitization of HO8910PM cell to cisplatin].
    Gao H; Shi J; Ge SF; DI W
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):45-9. PubMed ID: 18366933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
    Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway.
    Zhang J; Choi Y; Mavromatis B; Lichtenstein A; Li W
    Oncogene; 2003 Sep; 22(40):6289-95. PubMed ID: 13679867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the mammalian target of rapamycin inhibitor CCI-779 used alone or with chemotherapy on human prostate cancer cells and xenografts.
    Wu L; Birle DC; Tannock IF
    Cancer Res; 2005 Apr; 65(7):2825-31. PubMed ID: 15805283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
    Martelli AM; Tazzari PL; Tabellini G; Bortul R; Billi AM; Manzoli L; Ruggeri A; Conte R; Cocco L
    Leukemia; 2003 Sep; 17(9):1794-805. PubMed ID: 12970779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells.
    Grünwald V; DeGraffenried L; Russel D; Friedrichs WE; Ray RB; Hidalgo M
    Cancer Res; 2002 Nov; 62(21):6141-5. PubMed ID: 12414639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual silencing of the EGF and type 1 IGF receptors suggests dominance of IGF signaling in human breast cancer cells.
    Riedemann J; Sohail M; Macaulay VM
    Biochem Biophys Res Commun; 2007 Apr; 355(3):700-6. PubMed ID: 17320820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway.
    Deeb D; Jiang H; Gao X; Al-Holou S; Danyluk AL; Dulchavsky SA; Gautam SC
    J Pharmacol Exp Ther; 2007 May; 321(2):616-25. PubMed ID: 17289836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic effects of overexpression of the MMAC1 gene in prostate epithelial cells.
    Sharrard RM; Maitland NJ
    Br J Cancer; 2000 Oct; 83(8):1102-9. PubMed ID: 10993660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.